Fact based stock research
Brookdale (NYSE:BKD)


Brookdale stock research in summary

brookdaleliving.com


Brookdale shares have a SELL rating. They are bad value, are riskily financed, and show below average growth. We recommend selling Brookdale shares.


Latest Obermatt Ranks


Country USA
Industry Health Care Facilities
Index D.J. US Health Care
Size class Large

June 8, 2018. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()


Research History: Brookdale

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
34
41
43
42
STOCK GROWTH RANKS
39
34
1
1
STOCK SAFETY RANKS
1
1
1
6
COMBINED STOCK RANKS
9
7
18
1

Last update of Combined Rank: 8-Jun-2018. Stock research history is based on the Obermatt Method. The higher the rank, the better is Brookdale in the corresponding investment strategy.


Value Metrics in Detail

Last update of Value Rank: 8-Jun-2018. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Brookdale; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
79
29
2
5
PROFIT GROWTH
69
41
41
7
STOCK RETURNS
2
9
22
2
CONSOLIDATED RANK: GROWTH
39
34
1
1

Financial reporting date of Growth Rank: 31-Mar-2018. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Brookdale.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
7
1
1
1
REFINANCING
28
36
45
34
LIQUIDITY
3
2
8
1
CONSOLIDATED RANK: SAFETY
1
1
1
6

Financial reporting date of Safety Rank: 31-Mar-2018. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Brookdale and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Brookdale from June 8, 2018.